US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AI Healthcare

765.21

+26.013.52%

Number of Gainers:3

Number of Losers:1

Number of Flat:- -

PE:- -

High:766.70

Open:739.61

Low:739.37

Close:739.20

Loading ...

CRISPR Therapeutics Pick of the Week at Smart Insider Following Simeon George's Stock Purchase

MT Newswires Live

Tempus AI Inc. to Announce Second Quarter 2025 Financial Results

HIMS vs. LLY vs. TEM: Which Healthcare Stock Is Wall Street’s Top Buy Right Now?

Recursion Pharmaceuticals rises 10.7%

Recursion Pharmaceuticals (RXRX) Sees 14% Price Surge Over Last Month

Simply Wall St.

Crispr Therapeutics AG Stock Soars Amid Insider Confidence

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares

Recursion Pharmaceuticals call volume above normal and directionally bullish

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG!

CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares

Tempus AI (TEM) Gains FDA Clearance for New Cardiovascular Risk Detection Software

Simply Wall St.

Tempus Shares up 4.4% After U.S. FDA Clears Co's AI-Enabled Ecg Software

THOMSON REUTERS

Tempus AI Inc. Secures FDA 510(k) Clearance for AI-Driven Tempus ECG-Low EF Software to Enhance Cardiovascular Risk Detection

Tempus Receives U.S. FDA 510(K) Clearance for Tempus Ecg-Low Ef Software

THOMSON REUTERS

Crispr Therapeutics AG Stock Soars Amid Strategic Moves

Cathie Wood’s ARK Investment bought 16.2K shares of Tempus AI today

Moderately bullish activity in tempus AI Inc Class A with shares up 3.71%

The early winner in the 'Dexit' war for corporate relocations: Nevada

Personalis Expands Agreement with Tempus AI for Cancer Test

Personalis Inc. Expands Collaboration with Tempus AI to Market Cancer Test for Colorectal Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":765.20544,"timestamp":1753300799999,"preClose":739.1995,"halted":0,"volume":59575559,"delay":0,"changeRate":0.035181,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":26.00592,"latestTime":"07-23 16:00:00 EDT","open":739.605,"high":766.6976,"low":739.3718,"amount":1306542495.709414,"amplitude":0.036967,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.952975,"peRate":-10.143574,"turnoverRate":0.086191,"increases":3,"decrements":1,"flats":0,"marketCap":22134582016,"floatMarketCap":17051718272},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":766.6976,"amplitude":0.036967,"preClose":739.1995,"low":739.3718,"pbRate":"4.952975","latestPrice":765.20544,"volume":59575559,"delay":0,"open":739.605,"prevYearClose":530.4984,"prevWeekClose":719.1298,"prevMonthClose":637.8218,"prevQuarterClose":637.8218,"fiveDayClose":665.7215,"twentyDayClose":655.809,"sixtyDayClose":573.8122,"secType":"PLATE","market":"US","turnoverRate":0.086191,"peRate":-10.143574,"marketCap":22134582016,"floatMarketCap":17051718272,"timestamp":1753300799999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":3,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553158256","title":"CRISPR Therapeutics Pick of the Week at Smart Insider Following Simeon George's Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2553158256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553158256?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:09","pubTimestamp":1753189775,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics  was Smart Insider's stock pick of the week after the company's non-executive Simeon George bought 989,812 shares for $51.5 million on July 16 at $52.03 apiece, while \"more than doubling\" his stake.George bought the shares on behalf of SR One Capital Management, where he is the managing partner, Smart Insider said in a Tuesday note.Their only prior transactions were subscriptions for $931,000 in October 2016 and $75 million in February last year, the note added.\"We are also surprised to see the purchase, assuming the company is in a closed period with their results expected around the 10th of August,\" according to the note.Smart Insider ranked the stock +N, or notable & positive signal, on July 18.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4556","BK4007","BK4539","BK4588","BK4139","BK4611","LENZ","CRSP","MMAT","LU1861559042.SGD","LU1861558580.USD","BK4585"],"gpt_icon":1},{"id":"2553255938","title":"Tempus AI Inc. to Announce Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2553255938","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553255938?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:30","pubTimestamp":1753187431,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. will report financial results for the second quarter of 2025 on August 8, 2025. The results will be released on the company's Investor Relations website. A conference call will be held at 8:00 a.m. ET featuring Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast can be accessed through the events page of Tempus' Investor Relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL7y1Clq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861559042.SGD","LU1861558580.USD","TEM","BK4613","BK4121"],"gpt_icon":1},{"id":"2553409135","title":"HIMS vs. LLY vs. TEM: Which Healthcare Stock Is Wall Street’s Top Buy Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2553409135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553409135?lang=en_us&edition=fundamental","pubTime":"2025-07-22 03:24","pubTimestamp":1753125857,"startTime":"0","endTime":"0","summary":"Healthcare stocks tend to be resilient during economic downturns, as spending on medicines and medical treatments is often considered essential. Ho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-vs-lly-vs-tem-which-healthcare-stock-is-wall-streets-top-buy-right-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-vs-lly-vs-tem-which-healthcare-stock-is-wall-streets-top-buy-right-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203202063.USD","TEM","IE00BJLML261.HKD","LU0354030511.USD","LU1861558580.USD","LU0114720955.EUR","LU1061106388.HKD","LU2237443978.SGD","SG9999014898.SGD","SGXZ99366536.SGD","LU0203201768.USD","LU1804176565.USD","LU2089984988.USD","LU1232071149.USD","LU2462157665.USD","BK4196","LU0096364046.USD","LU1127390331.HKD","LU2357305700.SGD","LU2750360997.AUD","LU1861559042.SGD","SG9999015952.SGD","LU0820561909.HKD","LU0109391861.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU2237443895.HKD","LU0823416689.USD","LU2106854487.HKD","GB00BDT5M118.USD","HCSG","LU0417517546.SGD","LU0471298777.SGD","BK4611","LU1548497426.USD","LU2471134952.CNY","LU0234572021.USD","LU0106261372.USD","BK4613","BK4137","LLY","LU0266013472.USD","LU0882574055.USD","LU2468319806.SGD","LU0471298694.HKD","LU0238689110.USD","IE00BK4W5M84.HKD","LU1983299246.USD","HIMS","LU2324357040.USD"],"gpt_icon":0},{"id":"2553403789","title":"Recursion Pharmaceuticals rises 10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553403789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553403789?lang=en_us&edition=fundamental","pubTime":"2025-07-22 00:06","pubTimestamp":1753113960,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (RXRX) is up 10.7%, or 62c to $6.46. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-rises-10-7-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-rises-10-7-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4548","BK4609","BK4611","BK4139","RXRX"],"gpt_icon":0},{"id":"2552601410","title":"Recursion Pharmaceuticals (RXRX) Sees 14% Price Surge Over Last Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2552601410","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552601410?lang=en_us&edition=fundamental","pubTime":"2025-07-20 01:13","pubTimestamp":1752945192,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (RXRX) recently experienced a share price increase of 14% over the last month. This upward movement comes amid a flat broader market trend in the last week and coincides with a stable market performance rising 15% over the past year. While the latest key developments surrounding the company have not been provided, any events from the last month would either reinforce or counteract the broader market dynamics. Despite market predictions anticipating 15% annual...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/recursion-pharmaceuticals-rxrx-sees-14-price-surge-over-last","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4548","BK4139","BK4609","RXRX","BK4611","BK4539"],"gpt_icon":1},{"id":"2552474414","title":"Crispr Therapeutics AG Stock Soars Amid Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2552474414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552474414?lang=en_us&edition=fundamental","pubTime":"2025-07-19 22:03","pubTimestamp":1752933802,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 15.44%. Read on to learn why. Crispr Therapeutics AG has seen a notable 15.44% increase in its stoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4539","LENZ","BK4007","BK4139","BK4210","BK4585","BK4556","CRSP","BK4611","LU1861558580.USD","AG","LU1861559042.SGD"],"gpt_icon":0},{"id":"2552449489","title":"CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552449489","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552449489?lang=en_us&edition=fundamental","pubTime":"2025-07-19 00:57","pubTimestamp":1752857833,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics AG ($CRSP) hit a new 52-week high on Friday after an insider bought a large number of shares, which demonstrated that he was ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/crispr-therapeutics-crsp-surges-after-director-buys-over-51m-worth-of-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/crispr-therapeutics-crsp-surges-after-director-buys-over-51m-worth-of-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRSP","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4588","BK4585"],"gpt_icon":0},{"id":"2552406496","title":"Recursion Pharmaceuticals call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2552406496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552406496?lang=en_us&edition=fundamental","pubTime":"2025-07-18 23:05","pubTimestamp":1752851112,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 32,854 calls trading, 6x expected, and implied vol increasing almost 9 points...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-thefly-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-thefly-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4609","RXRX","BK4611","BK4139","BK4548"],"gpt_icon":0},{"id":"2552455535","title":"Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG!","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552455535?lang=en_us&edition=fundamental","pubTime":"2025-07-18 10:04","pubTimestamp":1752804275,"startTime":"0","endTime":"0","summary":"New insider activity at Crispr Therapeutics AG ( ($CRSP) ) has taken place on July 17, 2025. Director Simeon George has made a significant investme...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/director-makes-multi-million-dollar-investment-in-crispr-therapeutics-ag-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/director-makes-multi-million-dollar-investment-in-crispr-therapeutics-ag-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4585","BK4210","BK4588","CRSP","BK4141","BK4556","LU1861559042.SGD","BK4007","BK4611","BK4539","BK4139","LENZ","MMAT","AG"],"gpt_icon":0},{"id":"2552243413","title":"CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552243413","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552243413?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:19","pubTimestamp":1752787198,"startTime":"0","endTime":"0","summary":"George Simeon, a Director at CRISPR Therapeutics AG, reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLbCjmgX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4588","BK4611","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4585","CRSP"],"gpt_icon":0},{"id":"2552459310","title":"Tempus AI (TEM) Gains FDA Clearance for New Cardiovascular Risk Detection Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2552459310","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552459310?lang=en_us&edition=fundamental","pubTime":"2025-07-18 01:41","pubTimestamp":1752774109,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has recently secured FDA clearance for its Tempus ECG-Low EF software, an innovative AI-driven product aiding cardiovascular assessments. This development aligns with TEM’s aim to enhance its ECG-AI technology leadership, potentially strengthening its market position. Alongside, the company's improved Q1 earnings report, with notable revenue growth from $146 million to $256 million, reflects its robust performance. Additionally, Tempus’s expansion into new strategic...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-gains-fda-clearance-for-new-cardiovascular-ris","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","LU1861559042.SGD","TEM.AU","CSII","BK4613","BK4611","LU1861558580.USD","BK4121","BK4082","TEM"],"gpt_icon":1},{"id":"2551125204","title":"Tempus Shares up 4.4% After U.S. FDA Clears Co's  AI-Enabled Ecg Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551125204?lang=en_us&edition=fundamental","pubTime":"2025-07-16 21:57","pubTimestamp":1752674245,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nL4N3TD16Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","TEM","BK4613","BK4121","LU1861559042.SGD","LU1861558580.USD"],"gpt_icon":0},{"id":"2551400971","title":"Tempus AI Inc. Secures FDA 510(k) Clearance for AI-Driven Tempus ECG-Low EF Software to Enhance Cardiovascular Risk Detection","url":"https://stock-news.laohu8.com/highlight/detail?id=2551400971","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551400971?lang=en_us&edition=fundamental","pubTime":"2025-07-16 20:01","pubTimestamp":1752667292,"startTime":"0","endTime":"0","summary":"Tempus AI Inc. Secures FDA 510 Clearance for AI-Driven Tempus ECG-Low EF Software to Enhance Cardiovascular Risk Detection. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on July 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDL6g4Gl3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU1861558580.USD","LU1861559042.SGD","BK4611","TEM","BK4613"],"gpt_icon":1},{"id":"2551263140","title":"Tempus Receives U.S. FDA 510(K) Clearance for Tempus Ecg-Low Ef Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2551263140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551263140?lang=en_us&edition=fundamental","pubTime":"2025-07-16 20:00","pubTimestamp":1752667203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nTUA6S94N7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU1861559042.SGD","TEM","BK4611","LU1861558580.USD","BK4613"],"gpt_icon":0},{"id":"2550187959","title":"Crispr Therapeutics AG Stock Soars Amid Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2550187959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550187959?lang=en_us&edition=fundamental","pubTime":"2025-07-12 22:04","pubTimestamp":1752329091,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 10.96%. Read on to learn why. Crispr Therapeutics AG has seen a significant boost in its stock pric...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BK4588","BK4139","LENZ","LU1861559042.SGD","BK4611","BK4210","LU1861558580.USD","CRSP","AG","BK4556","BK4007"],"gpt_icon":0},{"id":"2550767075","title":"Cathie Wood’s ARK Investment bought 16.2K shares of Tempus AI today","url":"https://stock-news.laohu8.com/highlight/detail?id=2550767075","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550767075?lang=en_us&edition=fundamental","pubTime":"2025-07-11 09:00","pubTimestamp":1752195618,"startTime":"0","endTime":"0","summary":"20:57 EDT Cathie Wood’s ARK Investment bought 16.2K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-16-2k-shares-of-tempus-ai-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-16-2k-shares-of-tempus-ai-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKK","BK4544","LU1861559042.SGD","BK4585","BK4121","BK4611","LU1861558580.USD","TEM","BK4588","BK4613"],"gpt_icon":0},{"id":"2550204036","title":"Moderately bullish activity in tempus AI Inc Class A with shares up 3.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550204036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550204036?lang=en_us&edition=fundamental","pubTime":"2025-07-11 01:30","pubTimestamp":1752168609,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in tempus AI Inc Class A (TEM), with shares up $2.17, or 3.71%, near $60.58. Options volume roughly in line with averag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-tempus-ai-inc-class-a-with-shares-up-3-71-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-tempus-ai-inc-class-a-with-shares-up-3-71-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","LU1861559042.SGD","TEM","BK4121","LU1861558580.USD","BK4611"],"gpt_icon":0},{"id":"2550966255","title":"The early winner in the 'Dexit' war for corporate relocations: Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966255","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966255?lang=en_us&edition=fundamental","pubTime":"2025-07-10 16:00","pubTimestamp":1752134415,"startTime":"0","endTime":"0","summary":"More companies are following the example of Tesla's  Elon Musk and signing off on an exit from Delaware.But many are choosing Nevada — not Texas, as Musk did with Tesla in 2024 — as a new corporate home in 2025.The latest example came Wednesday when a high-profile venture capital firm, Andreessen Horowitz, announced it would move the incorporation of its primary business, AH Capital Management, from Delaware to Nevada as it offered a critique of Delaware's powerful business court.The VC firm long associated with Marc Andreessen accused the state's Chancery Court of injecting \"legal uncertainty\" into Delaware's reputation as the gold standard for corporate law.\"In contrast, Nevada has taken significant steps in establishing a technical, non-ideological forum for resolving business disputes,\" the company said.SANTA MONICA, CALIFORNIA - APRIL 05: Marc Andreessen and Laura Arrillaga-Andreessen attend the 2025 Breakthrough Prize Ceremony at Barker Hangar on April 05, 2025 in Santa Monica, C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/the-early-winner-in-the-dexit-war-for-corporate-relocations-nevada-080015108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4108","BK4099","TEM","BK4528","JBIO","LU0082616367.USD","LU0689472784.USD","BK4574","DBX","TSYW.SI","LU0348723411.USD","SG9999015952.SGD","SPHR","LU1852331112.SGD","BK4565","LU1861220033.SGD","BK4533","DXYZ","FNF","ULH","REVB","LU2326559502.SGD","SG9999001440.SGD","LU1720051017.SGD","LU0316494557.USD","BK4585","LU2087621335.USD","XOMA","LU0823414478.USD","LU0719512351.SGD","AMCX","BK4555","LU0820562030.AUD","SNOA","IE00BSNM7G36.USD","BK4592","LU0957808578.USD","IE00BK4W5M84.HKD","GXAI","LU1066053197.SGD","TTD","LU1674673428.USD","LU2750360641.GBP","OCTO","IE00BJLML261.HKD","MARK","LU1861558580.USD","BK4611","RBLX"],"gpt_icon":1},{"id":"2550665607","title":"Personalis Expands Agreement with Tempus AI for Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665607","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550665607?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:49","pubTimestamp":1752094160,"startTime":"0","endTime":"0","summary":"An update from Personalis ( ($PSNL) ) is now available. On July 8, 2025, Personalis, Inc. and Tempus AI, Inc. amended their existing agreement to i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/personalis-expands-agreement-with-tempus-ai-for-cancer-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/personalis-expands-agreement-with-tempus-ai-for-cancer-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","PSNL","LU1861559042.SGD","TEM","BK4611","LU1861558580.USD","BK4613"],"gpt_icon":0},{"id":"2550663310","title":"Personalis Inc. Expands Collaboration with Tempus AI to Market Cancer Test for Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663310","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663310?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:18","pubTimestamp":1752092306,"startTime":"0","endTime":"0","summary":"Personalis Inc. has announced an expansion of its partnership with Tempus AI, Inc., following the entry into Amendment No. 4 to their existing Commercialization and Reference Laboratory Agreement. Effective July 8, 2025, this amendment authorizes Tempus to market Personalis' ultra-sensitive NeXT Personal test for minimal residual disease in colorectal cancer, in addition to its current use in breast cancer, lung cancer, and immuno-oncology monitoring. The agreement, which has been extended to November 2029, also includes exclusivity provisions for colorectal cancer, prohibiting third parties from marketing similar tests and restricting Tempus from promoting competing assays until the end of 2028. This strategic move aims to strengthen their collaboration and market presence in the oncology diagnostics field.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL6DCx4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4613","LU1861559042.SGD","PSNL","BK4611","TEM","BK4121"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}